{"result": {"id": "e83116ad-a314-4583-9007-957e4e5cd553", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Fuwai Hospital and Peking University Third Hospital Cardiovascular Community\",\n    \"summary\": \"This community is centered around Fuwai Hospital, Chinese Academy of Medical Sciences, and Peking University Third Hospital, with a focus on cardiovascular disease research, treatment, and guideline development. Key entities include renowned cardiovascular experts such as Tang Yida, Wang Zengwu, and Li Jianjun, who are affiliated with these institutions. The community is characterized by its collaborative efforts in advancing cardiovascular medicine through clinical practice, research, and the development of national guidelines.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The high impact severity rating reflects the community's significant contributions to cardiovascular medicine, including guideline development and research, which have a broad influence on healthcare practices in China and potentially globally.\",\n    \"findings\": [\n        {\n            \"summary\": \"Fuwai Hospital as a Leading Cardiovascular Institution\",\n            \"explanation\": \"Fuwai Hospital, Chinese Academy of Medical Sciences, stands as a cornerstone in this community, renowned for its expertise in cardiovascular disease treatment and research. It hosts a multitude of distinguished cardiovascular experts and plays a pivotal role in the development of national guidelines for cardiovascular care. The hospital's influence extends beyond clinical practice to include significant contributions to academic research and policy-making in the field of cardiovascular health. [Data: Entities (1243, 1273, 1259, 1265, 1268, +more), Relationships (1060, 1056, 1058, 1059, 1061, +more)]\"\n        },\n        {\n            \"summary\": \"Peking University Third Hospital's Role in the Community\",\n            \"explanation\": \"Peking University Third Hospital complements the community with its broad medical expertise, including cardiovascular care. It is affiliated with experts like Tang Yida and Chen Yahong, who contribute to the hospital's reputation in medical research and clinical excellence. The hospital's collaboration with Fuwai Hospital underscores the interconnectedness of this community in advancing cardiovascular medicine. [Data: Entities (939, 936, 3085, 4584, 4614, +more), Relationships (734, 745, 2611, 4863, 4864, +more)]\"\n        },\n        {\n            \"summary\": \"Expert Contributions to Guideline Development\",\n            \"explanation\": \"Members of this community, such as Wang Zengwu and Li Jianjun, are instrumental in the development and revision of cardiovascular guidelines, including the Chinese Dyslipidemia Management Guidelines. Their work ensures that clinical practices in China are based on the latest evidence and research findings, significantly impacting patient care and outcomes. [Data: Entities (2245, 1264, 2186, 3088, 3101, +more), Relationships (1936, 1887, 1942, 2627, 2628, +more)]\"\n        },\n        {\n            \"summary\": \"International Collaboration and Influence\",\n            \"explanation\": \"The community's impact extends internationally through collaborations with entities like the European Atherosclerosis Society Consensus Panel. Such partnerships facilitate the exchange of knowledge and best practices in cardiovascular disease management, enhancing the global fight against cardiovascular diseases. [Data: Entities (3103, 4633, 4634, 4641, 4647, +more), Relationships (4891, 4894, 4895, 4900, 4901, +more)]\"\n        },\n        {\n            \"summary\": \"Research and Publication Contributions\",\n            \"explanation\": \"The community actively contributes to cardiovascular research, with findings published in prestigious journals such as the European Heart Journal and the Chinese Circulation Journal. These publications disseminate critical knowledge and guidelines, influencing both national and international cardiovascular care standards. [Data: Entities (2213, 4641, 4628, 3103, 4633, +more), Relationships (1942, 4900, 4891, 4894, 4895, +more)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752169051, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 837, "prompt_tokens": 7156, "total_tokens": 7993, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1472}, "prompt_cache_hit_tokens": 1472, "prompt_cache_miss_tokens": 5684}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        },\n        {\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        },\n        {\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        },\n        {\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }\n    ]\n}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n3813,陈吉棣,\"Professor Chen Jidi is a researcher at Peking University Third Hospital's Sports Medicine Institute, leading studies on aerobic exercise and lipid metabolism\",2\r\n1243,中国医学科学院阜外医院,\"中国医学科学院阜外医院（Fuwai Hospital, Chinese Academy of Medical Sciences）是中国领先的心血管疾病专科医院，隶属于中国医学科学院（Chinese Academy of Medical Sciences）。作为国内心血管领域的权威机构，该医院在临床诊疗、科研创新和指南制定方面具有重要影响力。部分心血管疾病指南编写专家组的成员来自该医院，凸显了其在行业内的专业地位和学术贡献。  \n\n该医院以“中国领先的心血管医院”著称，长期致力于心血管疾病的预防、治疗和研究工作，并在国内外享有较高声誉。其名称在不同语境下可能以“阜外医院”或“中国医学科学院阜外医院”出现，但均指向同一机构。作为医疗机构，它不仅是高水平医疗服务的提供者，同时也是心血管领域专家的重要执业和科研平台。  \n\n综上，中国医学科学院阜外医院是中国心血管医学领域的核心机构之一，集临床、科研和教学于一体，并在国家级指南制定中发挥关键作用。\",18\r\n1273,唐熠达,\"**唐熠达** is a distinguished medical professional specializing in cardiovascular medicine, affiliated with multiple prestigious institutions in China. He holds positions at both **Peking University Third Hospital** and the **Chinese Academy of Medical Sciences Fuwai Hospital**, reflecting his expertise and leadership in the field.  \n\nAs a **cardiovascular expert**, he is a member of the **cardiovascular expert group** at Fuwai Hospital, a renowned institution under the Chinese Academy of Medical Sciences. Additionally, he contributes to clinical guidelines as part of the **guideline revision expert group** at Peking University Third Hospital, underscoring his influence in shaping best practices in cardiovascular care.  \n\nHis dual affiliations highlight his collaborative role across leading medical centers, combining clinical practice, research, and policy development. While his primary associations are with Peking University Third Hospital and Fuwai Hospital, there is no contradiction in his roles; rather, they demonstrate his multidisciplinary engagement in advancing cardiovascular medicine in China.  \n\nIn summary, **唐熠达** is a highly respected cardiovascular specialist with significant contributions to both hospital-based care and national expert committees, bridging clinical excellence and academic leadership.\",2\r\n1259,冯广迅,冯广迅是中国医学科学院阜外医院的心血管专家，同时也是心血管专家组的成员。作为该领域的资深专业人士，他在心血管疾病的诊断、治疗和研究方面具有丰富的经验。冯广迅的学术背景和临床实践与中国医学科学院阜外医院这一国内顶尖心血管专科机构紧密关联，进一步凸显了他在心血管医学领域的权威性和贡献。他的双重身份——既是医院专家又是专家组成员——表明他在学术和临床实践中的积极参与，致力于推动心血管医学的发展与创新。,1\r\n1265,李萍,李萍是中国医学科学院阜外医院的心血管专家，同时也是心血管专家组的成员。作为该领域的资深专业人士，她在心血管疾病的诊断、治疗和研究方面具有丰富的经验。李萍的学术背景和临床实践与中国医学科学院阜外医院这一国内顶尖心血管专科医院的资源紧密结合，进一步巩固了她在心血管医学领域的权威地位。她的工作不仅涉及临床诊疗，还可能参与学术研究、政策制定或专业指导，为心血管健康领域的发展贡献力量。,1\r\n1268,梁岩,\"梁岩是中国医学科学院阜外医院的心血管专家，同时也是心血管专家组的成员。作为该领域的资深专业人士，梁岩在心血管疾病的诊断、治疗和研究方面具有丰富的经验和专业知识。他的工作单位阜外医院是中国顶尖的心血管病专科医院，隶属于中国医学科学院，以高水平的临床服务和科研能力著称。梁岩的专家身份和医院背景共同体现了他在心血管医学领域的重要地位和贡献。  \n\n（注：两段描述内容一致，仅中英文表述差异，故合并为统一陈述，未超500字限制。）\",1\r\n1276,翟玫,\"翟玫 is a cardiovascular expert and a member of the cardiovascular expert group. She is affiliated with the Chinese Academy of Medical Sciences Fuwai Hospital, a leading institution in cardiovascular medicine in China. As a specialist in her field, she contributes to the hospital's research, clinical practice, and expert consultations. Her role underscores her expertise and involvement in advancing cardiovascular health and treatment methodologies.\",1\r\n1278,张宇辉,\"张宇辉是心血管专家组成员，隶属于中国医学科学院阜外医院。作为心血管领域的资深专家，他在中国医学科学院阜外医院从事心血管相关的研究与临床工作。张宇辉的专业背景和机构 affiliation 表明他在心血管疾病领域具有权威性，并参与相关专家组的学术或临床决策工作。两份描述内容一致，共同强化了其作为阜外医院心血管专家的专业身份。  \n\n（注：英文部分\"\"affiliated with\"\"及\"\"cardiovascular\"\"保留原术语以保持机构名称和专业术语的准确性，中文部分已完整覆盖所有提供信息，总字数控制在500字以内。）\",1\r\n1280,朱俊,朱俊是中国医学科学院阜外医院的心血管专家，同时也是心血管专家组的成员。作为阜外医院——中国顶尖心血管疾病研究和诊疗机构的一员，他在心血管领域具备专业资质与临床经验。其双重身份（专家组与医院任职）表明他既参与学术或政策层面的协作工作，也从事一线医疗实践。两段描述内容一致，分别以中英文强调了其机构隶属与专业角色，并无矛盾。,1\r\n3070,吴娜琼,\"Member of the guideline revision expert group, affiliated with Fuwai Hospital, Chinese Academy of Medical Sciences\"\"\",1\r\n3076,周洲,\"Member of the guideline revision expert group, affiliated with Fuwai Hospital, Chinese Academy of Medical Sciences\"\"\",1\r\n3099,窦克非,\"A medical professional at the Chinese Academy of Medical Sciences Fuwai Hospital\"\"\",1\r\n3101,马丽媛,\"A member of the guideline revision secretariat, associated with the Chinese Academy of Medical Sciences Fuwai Hospital\"\"\",1\r\n3102,高莹,\"A member of the guideline revision secretariat, affiliated with the Chinese Academy of Medical Sciences Fuwai Hospital\"\"\",1\r\n1264,李建军,\"**Li Jianjun** is a distinguished chief physician and professor affiliated with Fuwai Hospital, Chinese Academy of Medical Sciences. He holds a prominent role as a cardiovascular expert, serving as a member of the cardiovascular expert group and contributing to significant medical guidelines in China. Li Jianjun is recognized as a corresponding author of the expert consensus on the comprehensive management of blood pressure and lipids in Chinese hypertensive patients, highlighting his leadership in the field. Additionally, he played a key role in the revision of clinical guidelines as a member of the guideline revision expert group at Fuwai Hospital. His expertise extends to dyslipidemia management, as evidenced by his authorship of the *Chinese Dyslipidemia Management Guidelines (2024 Edition)*. Collectively, his work underscores his influence in cardiovascular medicine, particularly in hypertension and lipid disorder management, and his institutional affiliation with one of China's leading medical research centers.\",5\r\n2186,中国血脂管理指南修订联合专家委员会,\"The **中国血脂管理指南修订联合专家委员会** (China Joint Expert Committee for Revision of Blood Lipid Management Guidelines) is a collaborative body of experts tasked with updating and refining China's national guidelines on blood lipid management. The committee is responsible for revising multiple versions of these guidelines, including the *China Lipid Management Guidelines (2023)* and the *Chinese Guideline for Lipid Management (Primary Care Version 2024)*.  \n\nComprising specialists in dyslipidemia and cardiovascular health, the committee ensures that the guidelines reflect the latest evidence-based practices for diagnosing, treating, and managing lipid disorders in China. Its work encompasses both primary care and specialized clinical settings, aiming to standardize and improve lipid management nationwide.  \n\nWhile the descriptions vary slightly in naming specific guideline versions (e.g., 2023 vs. 2024 editions), they consistently emphasize the committee's role as a joint expert group dedicated to maintaining up-to-date, authoritative recommendations for healthcare professionals. The discrepancies likely reflect iterative updates or different editions tailored to distinct audiences (e.g., specialists vs. primary care providers). Overall, the committee serves as the central authority for harmonizing lipid management practices across China's healthcare system.  \n\n(Word count: 178)\",11\r\n2185,“三高”共管规范化诊疗中国专家共识专家组,\"Expert group that developed the Chinese consensus on standardized management of \"\"three highs\"\" (hypertension, hyperlipidemia, and hyperglycemia)>\",2\r\n2213,中国循环杂志,\"*中国循环杂志* (*Chinese Circulation Journal*) is a Chinese medical journal specializing in research related to circulatory system diseases. It serves as an authoritative platform for disseminating scientific advancements and clinical practices in cardiology and vascular medicine. Among its notable contributions, the journal has published national guidelines on the management of hypertension and dyslipidemia, reinforcing its role in shaping evidence-based medical practices in China. By covering both original research and standardized treatment protocols, *中国循环杂志* plays a key role in advancing cardiovascular health and improving patient care standards nationwide.\",2\r\n3088,郭远林,\"**郭远林** is a medical expert affiliated with **Fuwai Hospital, Chinese Academy of Medical Sciences**. He holds a prominent role as a member of the **guideline revision expert group**, contributing his expertise to the development and refinement of medical guidelines. His association with Fuwai Hospital, a leading institution under the Chinese Academy of Medical Sciences, underscores his professional standing in the medical field. This dual affiliation highlights his involvement in both clinical practice and high-level advisory work, positioning him as a key figure in advancing medical standards and research.\",2\r\n3106,国家心血管病中心,,1\r\n4628,GLOBAL BURDEN OF CARDIOVASCULAR DISEASES AND RISKS,\"A study published in J Am Coll Cardiol on global cardiovascular disease burden\"\"\",1\r\n3103,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,\"The **European Atherosclerosis Society Consensus Panel** is an international expert panel composed of leading specialists in the field of cardiovascular disease. It is recognized for publishing authoritative consensus statements on atherosclerosis and related conditions, particularly atherosclerotic cardiovascular disease (ASCVD). In 2020, the panel released a significant consensus statement in the *European Heart Journal*, focusing on the role of low-density lipoproteins (LDL) in the development and management of ASCVD. This publication underscores the panel's commitment to advancing clinical understanding and guiding evidence-based practices in cardiovascular health.  \n\nAs a collaborative body of experts, the panel synthesizes current research and clinical insights to provide unified recommendations, aiding healthcare professionals in decision-making. Its work emphasizes the importance of LDL management in reducing cardiovascular risk, reflecting its broader mission to address key challenges in atherosclerosis. The European Atherosclerosis Society Consensus Panel serves as a vital resource for the medical community, ensuring that consensus-driven, up-to-date guidance is accessible to improve patient outcomes.\",11\r\n4633,KRAUSS RM,\"Krauss RM is one of the authors of the consensus statement from the European Atherosclerosis Society Consensus Panel published in the European Heart Journal in 2020.\"\"\",1\r\n4634,GINSBERG HN,\"Ginsberg HN is one of the authors of the consensus statement from the European Atherosclerosis Society published in the European Heart Journal in 2021.\"\"\",1\r\n4641,EUROPEAN HEART JOURNAL,\"The European Heart Journal published consensus statements from the European Atherosclerosis Society in 2020 and 2021.\"\"\",1\r\n4647,PACKARD CJ,\"Packard CJ is one of the authors of the consensus statement from the European Atherosclerosis Society published in 2021.\"\"\",1\r\n4648,CHAPMAN MJ,\"Chapman MJ is one of the authors of the consensus statement from the European Atherosclerosis Society published in 2021.\"\"\",1\r\n925,刘青,A general medicine expert from Peking University Third Hospital,2\r\n939,北京大学第三医院,\"**北京大学第三医院 (Peking University Third Hospital)** is a major tertiary hospital affiliated with Peking University, specializing in a wide range of medical fields. As a prominent healthcare institution, it serves as a key teaching and research hospital, hosting numerous medical experts and professionals. Among its affiliated experts are **陈亚红 (Chen Yahong)**, **Cui Ming**, **Zu Lingyun**, and **李小刚 (Li Xiaogang)**, who contribute to its reputation for excellence in clinical care, education, and research.  \n\nThe hospital is recognized for its comprehensive medical services and advanced specialties, reflecting its status as a leading institution under Peking University's healthcare network. Its affiliation with the university underscores its commitment to high standards in medical practice, innovation, and training. The presence of distinguished professionals like Chen Yahong, Cui Ming, Zu Lingyun, and Li Xiaogang further highlights its role as a hub for top-tier medical expertise.  \n\nIn summary, Peking University Third Hospital is a prestigious, university-affiliated tertiary hospital with a strong focus on multidisciplinary care, research, and education, supported by a team of renowned medical specialists.\",9\r\n936,陈亚红,陈亚红是一位呼吸系统疾病专家，目前任职于北京大学第三医院。她在呼吸医学领域具有深厚的专业知识和丰富的临床经验，专注于呼吸系统相关疾病的诊断、治疗与研究。作为北京大学第三医院呼吸科的资深专家，陈亚红在学术和医疗实践中均表现出色，致力于为患者提供高质量的医疗服务，并推动呼吸医学领域的进步。她的专业背景和医院 affiliation 突显了她在呼吸病学领域的权威性和影响力。,2\r\n2245,王增武,\"**Wang Zengwu** is a prominent medical expert affiliated with Fuwai Hospital, Chinese Academy of Medical Sciences, where he holds the position of chief physician and professor. He has played a significant role in the development and revision of medical guidelines in China, particularly in the fields of hypertension and dyslipidemia management.  \n\nWang Zengwu contributed to the *Expert Consensus on Comprehensive Management of Blood Pressure and Lipids in Chinese Hypertensive Patients* and was a corresponding author of the guideline. He is also recognized as a key figure in the revision of medical guidelines, serving as a member of the guideline revision expert group. Additionally, he was involved in the preparation of advisory documents and is one of the authors of the *Chinese Dyslipidemia Management Guidelines (2024 Edition)*.  \n\nHis work underscores his expertise in cardiovascular health, particularly in integrating blood pressure and lipid management strategies for hypertensive patients. As a leading figure at Fuwai Hospital, his contributions have helped shape clinical practices and guidelines in China.\",6\r\n3085,高炜,\"Member of the guideline revision expert group, affiliated with Peking University Third Hospital\"\"\",1\r\n4584,崔鸣,\"Cui Ming, a member of the expert group affiliated with Peking University Third Hospital\"\"\",1\r\n4614,祖凌云,\"Zu Lingyun, a member of the expert group affiliated with Peking University Third Hospital\"\"\",1\r\n4615,范媛媛,\"Fan Yuanyuan, a member of the consensus writing secretariat affiliated with Peking University Third Hospital\"\"\",1\r\n2270,陈源源,\"A contributor to the expert consensus on comprehensive management of blood pressure and lipids in Chinese hypertensive patients\"\"\",2\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\r\n3773,陈吉棣,高脂血症,Chen Jidi conducts research on the effects of aerobic exercise on high lipid levels,236\r\n1060,中国医学科学院阜外医院,唐熠达,中国医学科学院阜外医院（Chinese Academy of Medical Sciences Fuwai Hospital）是一家专注于心血管疾病治疗与研究的知名医疗机构。唐熠达（Tang Yida）是该医院的心血管专家，长期从事心血管领域的临床与科研工作。作为中国医学科学院阜外医院的资深医师，他在心血管疾病的诊断、治疗及研究方面具有丰富的经验和专业知识。唐熠达的学术背景和临床实践与该医院的使命高度契合，进一步巩固了阜外医院在心血管医学领域的领先地位。,20\r\n1056,中国医学科学院阜外医院,冯广迅,中国医学科学院阜外医院（Chinese Academy of Medical Sciences Fuwai Hospital）是一家专注于心血管疾病研究和治疗的知名医疗机构。冯广迅（Feng Guangxun）是该医院的心血管专家，长期致力于心血管领域的临床与科研工作。作为中国医学科学院阜外医院的成员，冯广迅在心血管疾病的诊断、治疗及研究方面具有丰富的经验和专业知识，为该领域的学术发展和医疗实践做出了贡献。他的工作体现了该医院在心血管健康领域的领先地位和学术影响力。,19\r\n1058,中国医学科学院阜外医院,李萍,中国医学科学院阜外医院（Chinese Academy of Medical Sciences Fuwai Hospital）是一家专注于心血管疾病研究和治疗的知名医疗机构。李萍（Li Ping）是该医院的心血管专家，长期从事心血管领域的临床与科研工作。作为中国医学科学院阜外医院的成员，李萍在心血管疾病的诊断、治疗及研究方面具有丰富的经验和专业知识，为该领域的学术发展和患者救治做出了贡献。她的工作体现了该医院在心血管医疗领域的领先地位和学术影响力。,19\r\n1059,中国医学科学院阜外医院,梁岩,\"中国医学科学院阜外医院（Chinese Academy of Medical Sciences Fuwai Hospital）是一家专注于心血管疾病研究和治疗的知名医疗机构。梁岩（Liang Yan）是该医院的心血管专家，长期从事心血管领域的临床与科研工作。作为中国医学科学院阜外医院的资深成员，梁岩在心血管疾病的诊断、治疗及研究方面具有丰富的经验和专业知识，为该领域的学术发展和医疗实践做出了贡献。  \n\n梁岩的学术背景和临床实践与中国医学科学院阜外医院的使命高度契合，该医院作为国内领先的心血管病专科医院，致力于推动心血管医学的进步，并为患者提供高水平的医疗服务。梁岩的工作进一步巩固了医院在心血管领域的权威地位。\",19\r\n1061,中国医学科学院阜外医院,翟玫,中国医学科学院阜外医院（Chinese Academy of Medical Sciences Fuwai Hospital）是一家专注于心血管疾病研究和治疗的知名医疗机构。翟玫（Zhai Mei）是该医院的心血管专家，长期从事心血管领域的临床与科研工作。作为中国医学科学院阜外医院的成员，翟玫在心血管疾病的诊断、治疗及研究方面具有丰富的经验和专业知识，致力于为患者提供高质量的医疗服务，并推动心血管医学的发展。她的工作体现了该医院在心血管领域的领先地位和学术影响力。,19\r\n1062,中国医学科学院阜外医院,张宇辉,中国医学科学院阜外医院（Chinese Academy of Medical Sciences Fuwai Hospital）是一家专注于心血管疾病治疗与研究的知名医疗机构。张宇辉（Zhang Yuhui）是该医院的心血管专家，长期从事心血管领域的临床与科研工作。作为中国医学科学院阜外医院的资深医师，张宇辉在心血管疾病的诊断、治疗及研究方面具有丰富的经验和专业知识，为该医院在心血管领域的卓越声誉作出了贡献。他的工作体现了该医院在心血管医疗和研究方面的领先地位。,19\r\n1064,中国医学科学院阜外医院,朱俊,中国医学科学院阜外医院（Chinese Academy of Medical Sciences Fuwai Hospital）是一家专注于心血管疾病治疗与研究的知名医疗机构。朱俊（Zhu Jun）是该医院的心血管专家，长期从事心血管领域的临床与科研工作。作为中国医学科学院阜外医院的资深成员，朱俊在心血管疾病的诊断、治疗及研究方面具有丰富的经验和专业知识。他的工作与医院在心血管领域的卓越贡献密切相关，进一步巩固了该机构在该学科领域的领先地位。,19\r\n2578,中国医学科学院阜外医院,吴娜琼,\"吴娜琼 is affiliated with Fuwai Hospital, Chinese Academy of Medical Sciences\",19\r\n2579,中国医学科学院阜外医院,周洲,\"周洲 is affiliated with Fuwai Hospital, Chinese Academy of Medical Sciences\",19\r\n2617,中国医学科学院阜外医院,窦克非,窦克非 is a medical professional at the Chinese Academy of Medical Sciences Fuwai Hospital,19\r\n2618,中国医学科学院阜外医院,马丽媛,\"马丽媛 is a member of the guideline revision secretariat, associated with the Chinese Academy of Medical Sciences Fuwai Hospital\",19\r\n2619,中国医学科学院阜外医院,高莹,\"高莹 is a member of the guideline revision secretariat, affiliated with the Chinese Academy of Medical Sciences Fuwai Hospital\",19\r\n1936,李建军,中国血脂管理指南修订联合专家委员会,李建军 is a member of the Chinese dyslipidemia management guidelines revision joint expert committee,16\r\n1887,“三高”共管规范化诊疗中国专家共识专家组,中国血脂管理指南修订联合专家委员会,Both develop consensus and guidelines for managing lipid disorders and related conditions in China,13\r\n1942,中国血脂管理指南修订联合专家委员会,中国循环杂志,The committee published guidelines in the journal 中国循环杂志,13\r\n2627,郭远林,中国血脂管理指南修订联合专家委员会,Guo Yuanlin is part of the expert committee revising China's blood lipid management guidelines,13\r\n2628,中国血脂管理指南修订联合专家委员会,国家心血管病中心,The National Center for Cardiovascular Diseases is involved in the revision of China's blood lipid management guidelines,12\r\n4891,GLOBAL BURDEN OF CARDIOVASCULAR DISEASES AND RISKS,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,The study references consensus statements from the European Atherosclerosis Society,12\r\n4894,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,KRAUSS RM,Krauss RM is one of the authors of the consensus statement from the European Atherosclerosis Society Consensus Panel,12\r\n4895,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,GINSBERG HN,Ginsberg HN is one of the authors of the consensus statement from the European Atherosclerosis Society,12\r\n4900,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,EUROPEAN HEART JOURNAL,The Consensus Panel published their statements in the European Heart Journal,12\r\n4901,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,PACKARD CJ,Packard CJ is an author of the consensus statement from the European Atherosclerosis Society,12\r\n4902,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,CHAPMAN MJ,Chapman MJ is an author of the consensus statement from the European Atherosclerosis Society,12\r\n734,刘青,北京大学第三医院,刘青 works at Peking University Third Hospital,11\r\n745,陈亚红,北京大学第三医院,\"陈亚红 is a respiratory disease expert at Peking University Third Hospital (also known as Peking University Third Hospital). She is affiliated with the hospital, where she specializes in the field of respiratory medicine. Her role at the institution highlights her expertise in diagnosing and treating respiratory conditions, contributing to the hospital's medical and research efforts in this area. The descriptions consistently emphasize her professional association with Peking University Third Hospital and her specialization in respiratory diseases, with no contradictory information.\",11\r\n1934,王增武,李建军,王增武 and 李建军 are co-authors of the Chinese dyslipidemia management guidelines (2024 edition),11\r\n2612,北京大学第三医院,唐熠达,\"Tang Yida (唐熠达) is affiliated with Peking University Third Hospital (北京大学第三医院). He holds a professional association with the institution, indicating his involvement in its medical, academic, or administrative activities. Both descriptions consistently confirm his connection to the hospital, with no contradictory information. As a result, it can be conclusively stated that Tang Yida is linked to Peking University Third Hospital in a professional capacity.\",11\r\n2611,高炜,北京大学第三医院,高炜 is affiliated with Peking University Third Hospital,10\r\n4863,崔鸣,北京大学第三医院,Cui Ming is affiliated with Peking University Third Hospital,10\r\n4864,北京大学第三医院,祖凌云,Zu Lingyun is affiliated with Peking University Third Hospital,10\r\n4865,北京大学第三医院,范媛媛,Fan Yuanyuan is affiliated with Peking University Third Hospital,10\r\n1964,陈源源,王增武,陈源源 and 王增武 co-authored an expert consensus on hypertension management,8\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_ac22605b58bb183295a228b4331cb0697f308534b1c0ff226fa3f3b6f7db88a9_v2"}